IRLAB Therapeutics AB
STO:IRLAB A

Watchlist Manager
IRLAB Therapeutics AB Logo
IRLAB Therapeutics AB
STO:IRLAB A
Watchlist
Price: 12.6 SEK -1.95% Market Closed
Market Cap: 652.5m SEK
Have any thoughts about
IRLAB Therapeutics AB?
Write Note

IRLAB Therapeutics AB
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

IRLAB Therapeutics AB
Revenue Peer Comparison

Comparables:
CALTX
CAMX
S
SECARE
MOB
I
FLERIE

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
IRLAB Therapeutics AB
STO:IRLAB A
Revenue
kr5.7m
CAGR 3-Years
N/A
CAGR 5-Years
216%
CAGR 10-Years
N/A
Calliditas Therapeutics AB
STO:CALTX
Revenue
kr1.6B
CAGR 3-Years
1 488%
CAGR 5-Years
63%
CAGR 10-Years
N/A
Camurus AB
STO:CAMX
Revenue
kr1.6B
CAGR 3-Years
50%
CAGR 5-Years
94%
CAGR 10-Years
N/A
S
Swedencare AB (publ)
STO:SECARE
Revenue
kr2.5B
CAGR 3-Years
75%
CAGR 5-Years
85%
CAGR 10-Years
N/A
Moberg Pharma AB (publ)
STO:MOB
Revenue
kr0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
I
InDex Pharmaceuticals Holding AB
STO:FLERIE
Revenue
kr100k
CAGR 3-Years
123%
CAGR 5-Years
0%
CAGR 10-Years
N/A

See Also

What is IRLAB Therapeutics AB's Revenue?
Revenue
5.7m SEK

Based on the financial report for Dec 31, 2023, IRLAB Therapeutics AB's Revenue amounts to 5.7m SEK.

What is IRLAB Therapeutics AB's Revenue growth rate?
Revenue CAGR 5Y
216%

Over the last year, the Revenue growth was -91%.

Back to Top